Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00246_DB00875_nanopub.RAu6KoGcSRDQ9X1bky4AmQ7BxuwfLeBNmn3dV8N2Sg_xw#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00246_DB00875 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00246_DB00875 label "DDI between Ziprasidone and Flupentixol - Additive QTc-prolonging effects may increase the risk of severe arrhythmias. Concomitant therapy is contraindicated. [drugbank_resource:DB00246_DB00875]" assertion.
- drugbank_resource:DB00246_DB00875 identifier "drugbank_resource:DB00246_DB00875" assertion.
- drugbank_resource:DB00246_DB00875 title "DDI between Ziprasidone and Flupentixol - Additive QTc-prolonging effects may increase the risk of severe arrhythmias. Concomitant therapy is contraindicated." assertion.
- drugbank:DB00246 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00246_DB00875 assertion.
- drugbank:DB00875 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00246_DB00875 assertion.